Seven Fortune 500 Companies That Secretly Run Your Life
These companies may not get a lot of attention, but they define the course of our lives in more ways than you might imagine.
These companies may not get a lot of attention, but they define the course of our lives in more ways than you might imagine.
For millions of Americans, Medicare is a major key to a secure retirement, but over the years, it's gotten increasingly complex. Here's the simple version of how it all works.
Shares of health insurance provider Humana jumped yesterday and are set to gain more today following news that Medicare Advantage might increase reimbursement rates.
Reports that retailers Office Depot and OfficeMax are discussing a merger came after big corporate deals for Heinz and Dell were announced in recent weeks. Some investors are betting that more deals could be on the way as buyers pay premium prices for publicly traded companies.
Millions of seniors enrolled in some of the most popular Medicare prescription drug plans face double-digit premium hikes next year if they don't shop for a better deal, says a private firm that analyzes the highly competitive market.
The recent pushback on health care reform appears to have boosted the stock prices of health insurance companies, which have outperformed major indexes by quite a margin so far this year. That's because Americans have been cutting back on doctor visits, keeping reimbursement costs low.
Humana reported diluted earnings per common share of $2 for the second quarter, up from $1.67 in the second quarter of 2009.
One in five medical claims is processed inaccurately by health insurers, the American Medical Association said on Monday. Eliminating these errors could save the health care system save $15.5 billion of the $210 billion it spends annually on claims processing.
Medco Health Solutions's purchase of DNA Direct may be small in size but big in potential. It bolsters the pharmacy benefits manager's footprint in personalized medicine, a fast-growing field that uses a patient's genetic data to better target health-care treatments.
President Obama can't be pleased by the loss of a Democratic Senate seat which jeopardizes passage of his cherished health-care reform. The news, however, appears to have fueled a mini stock rally in the health-care and pharma sectors wary of how any reform would affect their businesses. The uptrend is expected to continue.










